Full Text View
Tabular View
No Study Results Posted
Related Studies
Sildenofil in Persistent Pulmonary Hypertension in Newborns
This study is currently recruiting participants.
Verified September 2012 by Hamad Medical Corporation
Study NCT01558466   Information provided by Hamad Medical Corporation

First Received on March 11, 2012.   Last Updated on September 23, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Hypertension
Hypertension, Pulmonary
Persistent Fetal Circulation Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Infant, Newborn, Diseases
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Sildenafil
diluent
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Hamad Medical Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services